Gallagher re global insurtech report : Q4 2022 (February 2023)

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Gallagher Re</dc:creator>
<dc:date>2023</dc:date>
<dc:description xml:lang="es">Sumario: 2022 began with a lot of uncertainty, with a number of macroeconomic factors (many not directly relating to (re)insurance) impacting venture capital and the general bullishness in our industry of the impact that technology was actually having (relative to the cost). With the downturn of investment came the revision of company values and a rethinking of what success' should mean in a more conservative environment. As a direct result, the ability to leverage individual company equity for loss-propping risk capacity became increasingly difficult, and several InsurTechs had some very challenging decisions to make as they reviewed their own margins and likelihood of (near term) future rounds </dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/182213.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>Gallagher Re</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Insurtech</dc:subject>
<dc:subject xml:lang="es">Empresas de seguros</dc:subject>
<dc:subject xml:lang="es">Mercado de seguros</dc:subject>
<dc:subject xml:lang="es">Incertidumbre</dc:subject>
<dc:subject xml:lang="es">Inversiones</dc:subject>
<dc:subject xml:lang="es">Capital riesgo</dc:subject>
<dc:type xml:lang="es">Books</dc:type>
<dc:title xml:lang="es">Gallagher re global insurtech report : Q4 2022 (February 2023)</dc:title>
<dc:format xml:lang="es">88 p.</dc:format>
</rdf:Description>
</rdf:RDF>